How effective are linezolide and telithromycin? The resistance situation of gram-positive bacterial pathogens in Germany;Wie wirksam sind linezolid und telithromycin? Resistenzsituation bei grampositiven infektionserregern in Deutschland

Pharmazie in Unserer Zeit

Volumn 33, Issue 1, 2004, Pages 20-27

  Kresken, Michael ^a  

^a Antiinfectives Intell Gesellschaft   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; GLYCOPEPTIDE; LINCOSAMIDE; LINEZOLID; MACROLIDE; METICILLIN; OXACILLIN; PENICILLIN DERIVATIVE; TELITHROMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG EFFICACY; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GERMANY; GRAM POSITIVE BACTERIUM; HOSPITAL INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PENICILLIN RESISTANCE; PHENOTYPE; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

ACETAMIDES; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; GERMANY; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; KETOLIDES; MACROLIDES; OXAZOLIDINONES;

EID: 0742289185     PISSN: 00483664     EISSN: None     Source Type: Journal    
DOI: 10.1002/pauz.200400051     Document Type: Article

References (39)

1. Kresken, M., Hafner, D., Witte, W., Reinert, R.R., Chemother J 8 (1999) 136-145
2. Kresken, M., Hafner, D., Chemother J 9 (2000) 51-86
3. Kresken, M., Hafner, D., Schmitz, F.-J., Wichelhaus, T.A. für die Studiengruppe: Resistenzsituation bei klinisch wichtigen Infektionserregern gegenüber Antibiotika in Deutschland und im mitteleuropäischen Raum. Bericht über die Ergebnisse einer multizentrischen Studie der Arbeitsgemeinschaft Empfindfichkeitsprüfungen und Resistenz der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. aus dem Jahre 2001. Antiinfectives Intelligence, Bonn, 2003.
4. EARSS, European Antimicrobial Resistance Surveillance System. EARSS Annual Report 2001. EARSS, Bilthoven, The Netherlands, July 2002
5. Bierbaum, G., Fuchs, K., Lenz, W. et al., Eur J Clin Microbiol Infect Dis 18 (1999) 691-696
6. Geisel, R., Schmitz, F.-J., Thomas, L. et al., J Antimicrob Chemother 43 (1999) 846-848
7. Centers for Disease Control and Prevention, MMWR Morb Mortal Wkly Rep 51 (2002) 565-567
8. Centers for Disease Control and Prevention, MMWR Morb Mortal Wkly Rep 51 (2002) 902
9. National Nosocomial Infections Surveillance System. Am J Infect Control 30 (2002) 458-475
10. Felmingham, D., Reinert, R.R., Hirakata, Y., Rodloff, A., J Antimicrob Chemother 50 Suppl S1 (2002) 25-37
11. Henrichfreise, B., Wiedemann, B., Bagel, S. et al., Abstract 1055, Clin Microbiol Intect 9 Suppl 1 (2003) 247
12. Kresken, M., Brauers, J., Bagel, S., Abstract 1575, Clin Microbiol Infect 9 Suppl 1 (2003) 384-385
13. Reinert, R.R., Al-Laham, A., Schorn, H.M. et al., 40th ICAAC, Toronto, Canada, 17.-20. September 2000, Abstract 2150
14. Reinert, R.R., Al-Laham, A., Lemperle, M. et al., J Antimicrob Chemother 49 (2002) 61-68
15. Reinert, R.R., Rodloff, A.C., Halle, E., Abstract 1100, Clinical Microbiol Infect 8 Suppl 1 (2002) 248
16. Reinert, R.R., Lütticken, R., Bryskier, A., Al-Lahham, A., Antimicrob Agents Chemother 47 (2003) 489-493
17. Reinert, R.R., Neuberger, N., Cil, M. et al., Abstract 1574, Clin Microbiol Infect 9 Suppl 1 (2003) 384
18. Fujíta, K., Murono, K., Yoshikawa, M., Murai, T., Pediatr Infect Dis J 13 (1994) 1075-1078
19. Holmström, L., Nyman, B., Rosengren, M. et al., Scand J Infect Dis 22 (1990) 179-185
20. Seppälä, H., Nissinen, A., Jarvinen, H. et al., N Engl J Med 326 (1992) 292-297
21. Halle, E., Majchor-Peszynska, J., Drewelow, B., Chemother J 11 (2002) 1-11
22. Shain, C. S., Amsden, G. W., Ann Pharmacother 36 (2002) 452-464
23. Carbon, C., Roos, K., Rangaraju M., Nustrat, R., Abstract 1127, Clin Microbiol Infect 9 Suppl 1 (2003) 265-266
24. Cantón, R., Loza, E., Morosini, M.I., Baquero F., J Antimicrob Chemother 50 Suppl S1 (2002) 9-24
25. Brauers, J., Bagel, S., Kresken, M., 42nd ICAAC, San Diego, CA, USA, 27.-30. September 2002, Abstract E-1896
26. Brauers, J., Kresken, M., Shah, P., Abstract 1575, Clin Microbiol Infect 9 Suppl 1 (2003) 351
27. Swaney, S.M., Shinabarger, D.L., Schaadt, R.D. et al., 38th ICAAC, San Diego, USA, 24.-27. September 1998, Abstract C-104
28. Huppertz, K., Wiedemann, B., GENARS-Projektgruppe, Chemother J 11 (2002) 102-104
29. Zurenko, G.E., Yagi, B.H., Schaadt, R.D et al., Antimicrob Agents Chemother 40 (1996) 839-845
30. Kaatz, G.W., Seo, S.M., Antimicrob Agents Chemother 40 (1996) 799-801
31. Livermore, D.M., J Antimicrob Chemother 51 Suppl 2 (2003) 119-1116
32. Gonzales, R.D., Schreckenberger, P.C., Graham, M.B. et al., Lancet 357 (2001) 1179
33. Auckland, C., Teare, L., Cooke, F. et al., J Antimicrob Chemother 50 (2002) 743-746
34. Johnson, A.P., Tysall, L., Stockdale, M.V., Eur J Clin Microbiol Infect Dis 21 (2002) 751-754
35. Tsiodras, S., Gold, H.S., Sakoulas, G. et al., Lancet 358 (2001) 207-208
36. Wilson, P., Andrews, J.A., Charlesworth, R. et al., J Antimicrob Chemother 51 (2003) 186-188
37. Farrell, D.J., Morrissey, I., Bakker, S. et al., J Antimicrob Chemother 50 Suppl S1 (2002) 39-47
38. Lina, G., Quaglia, A., Reverdy, M.E. et al., Antimicrob Agents Chemother 43 (1999) 1062-1066
39. Schmitz, F.J., Petridou, J., Fluit, A.C. et al., Eur J Clin Microbiol Infect Dis 19 (2000) 385-387